Tg Therapeutics' 15-minute chart shows KDJ Death Cross, Bearish Marubozu signal.
PorAinvest
miércoles, 6 de agosto de 2025, 12:04 pm ET1 min de lectura
EFSI--
The KDJ Death Cross and Bearish Marubozu pattern have been observed in other stocks as well, such as Eagle Financial, Telix, and SABESP, which have shown similar bearish signals [2][3]. Investors should closely monitor TG Therapeutics for further signs of downward trends.
In addition to the technical indicators, TG Therapeutics recently reported its second-quarter earnings, which were mixed. The company reported earnings of 17 cents per share, substantially missing the Zacks Consensus Estimate of 32 cents. Revenues in the second quarter totaled $141.1 million, up almost 92% year over year, driven by the strong demand for the company’s sole marketed drug, Briumvi (ublituximab-xiiy) [4].
The recent technical analysis and earnings report suggest that investors should be cautious about TG Therapeutics stock. The bearish momentum indicated by the KDJ Death Cross and Bearish Marubozu pattern, along with the mixed earnings announcement, may signal further potential declines in the stock price.
References:
[1] https://www.ainvest.com/news/trip-15-minute-chart-triggers-kdj-death-cross-bearish-marubozu-2508/
[2] https://www.ainvest.com/news/eagle-financial-15min-chart-triggers-kdj-death-cross-bearish-marubozu-signal-2507/
[3] https://www.ainvest.com/news/telix-15min-chart-triggers-kdj-death-cross-bearish-marubozu-pattern-2507/
[4] https://www.barchart.com/story/news/33894778/tgtx-down-as-q2-earnings-miss-mark-briumvi-sales-drive-top-line
SBS--
TGTX--
TLX--
At Tg Therapeutics, the 15-minute chart has recently indicated a KDJ Death Cross and a Bearish Marubozu, which occurred on August 6th at 12:00. This suggests that the momentum of the stock price is shifting in a downward direction and has the potential to further decline. The sellers are currently in control of the market, and it is likely that this bearish momentum will continue.
TG Therapeutics (TGTX) has recently experienced a significant shift in its stock price momentum, as indicated by a KDJ Death Cross and a Bearish Marubozu on its 15-minute chart. This technical analysis suggests a potential downward trend, with sellers currently dominating the market. The KDJ Death Cross, a reversal pattern, occurs when the K-line crosses below the J-line on the KDJ indicator, signaling a potential trend reversal [1]. The Bearish Marubozu pattern, characterized by a single candle with no upper or lower wick, indicates that the stock has been trading within a narrow range, with sellers dominating the market [1].The KDJ Death Cross and Bearish Marubozu pattern have been observed in other stocks as well, such as Eagle Financial, Telix, and SABESP, which have shown similar bearish signals [2][3]. Investors should closely monitor TG Therapeutics for further signs of downward trends.
In addition to the technical indicators, TG Therapeutics recently reported its second-quarter earnings, which were mixed. The company reported earnings of 17 cents per share, substantially missing the Zacks Consensus Estimate of 32 cents. Revenues in the second quarter totaled $141.1 million, up almost 92% year over year, driven by the strong demand for the company’s sole marketed drug, Briumvi (ublituximab-xiiy) [4].
The recent technical analysis and earnings report suggest that investors should be cautious about TG Therapeutics stock. The bearish momentum indicated by the KDJ Death Cross and Bearish Marubozu pattern, along with the mixed earnings announcement, may signal further potential declines in the stock price.
References:
[1] https://www.ainvest.com/news/trip-15-minute-chart-triggers-kdj-death-cross-bearish-marubozu-2508/
[2] https://www.ainvest.com/news/eagle-financial-15min-chart-triggers-kdj-death-cross-bearish-marubozu-signal-2507/
[3] https://www.ainvest.com/news/telix-15min-chart-triggers-kdj-death-cross-bearish-marubozu-pattern-2507/
[4] https://www.barchart.com/story/news/33894778/tgtx-down-as-q2-earnings-miss-mark-briumvi-sales-drive-top-line
Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios